Work

7163 Phase II study of eribulin (Halichondrin B analogue, E7389) in patients with advanced urothelial cancer (AUC) – California Cancer Consortium led NCI/CTEP-sponsored trial

Year: 2009

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(09)71496-x

Authors: D.I. Quinn, A.M. Aparicio, D.D. Tsao-Wei, S. Groshen, T. Synold, W.M. Stadler, K. Massopust, D. Gandara, P.N. Lara, E. Newman

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2128678068

Cites:

Cited by: 2

Related to: 10